Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

Tiobarbital B. Braun 1 g powder for solution for injection

tiopental sodium

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the pack

  1. What Tiobarbital B. Braun 1g is and what it is used for
  2. What you need to know before you use Tiobarbital B. Braun 1 g
  3. How to use Tiobarbital B. Braun 1 g
  4. Possible side effects
  5. Storage of Tiobarbital B. Braun 1 g
  6. Contents of the pack and other information

1. What Tiobarbital B. Braun 1 g is and what it is used for

This medicine contains the active substance tiopental sodium and sodium carbonate. It is a thiobarbiturate with rapid onset for intravenous administration.

Tiobarbital B. Braun is used in adults:

  • for short surgical interventions as a single anesthetic agent for the induction and maintenance of anesthesia,
  • in combination with other agents used in general anesthesia for the induction and maintenance of anesthesia,
  • to control convulsions that may occur with some types of anesthesia or due to other causes,
  • to induce emergency coma during a prolonged epileptic crisis (refractory status epilepticus),
  • to induce and maintain barbiturate coma intended to reduce intracranial pressure in patients where pressure increases and other therapeutic measures have failed.

Tiobarbital B. Braun is used in children:

  • for short surgical interventions as a single anesthetic agent for the induction and maintenance of anesthesia,
  • in combination with other agents used in general anesthesia for the induction and maintenance of anesthesia,
  • to control convulsions that may occur with some types of anesthesia or due to other causes,
  • to induce emergency coma during a prolonged epileptic crisis (refractory status epilepticus).
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Tiobarbital B. Braun 1 g

Do not use Tiobarbital B. Braun:

  • if you are allergic to barbiturates or to any of the components of this medicine (listed in section 6),
  • if you have a respiratory obstruction (respiratory obstruction),
  • if you have acute asthma (severe asthma attack),
  • if you suffer from hereditary muscular dystrophy (myotonic dystrophy),
  • if you are in severe shock,
  • if you have a metabolic disorder called porphyria (hereditary disease, caused by a deficiency in the enzymes involved in the synthesis of a component of hemoglobin found in red blood cells).

Warnings and precautions:

Consult your doctor or pharmacist before starting to use Tiobarbital B. Braun, especially if you have:

  • increased intracranial pressure,
  • asthma or other severe respiratory disease,
  • inflammation in the mouth, jaw, and throat, which could lead to respiratory problems during the use of tiopental,
  • any heart or blood vessel disease or high blood pressure,
  • inflammation of the sac around the heart,
  • dehydration or decreased total blood volume (hypovolemia),
  • severe bleeding or burns,
  • severe myasthenia (a condition in which muscles become easily fatigued and weakened),
  • reduced function of the adrenal gland, even when treated with cortisone,
  • weakness, malnutrition, and weight loss,
  • increased levels of urea, toxins, or potassium in the blood,
  • severe anemia,
  • shock,
  • liver or kidney problems,
  • any metabolic disorder, such as thyrotoxicosis, myxedema, and diabetes,
  • alcohol or drug addiction.

Using Tiobarbital B. Braun with other medicines:

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

The medicines that may affect or interact with tiopental are the following:

  • Aminophylline (for the treatment of asthma).
  • Midazolam (a sedative medicine).
  • Opioid analgesics (medicines for treating strong pain).
  • Probenecid (a medicine for treating gout).
  • Fentanyl (a medicine for treating pain).
  • Muscle relaxants.
  • Monoamine oxidase inhibitors and tricyclic antidepressants (medicines used for treating depression), such as citalopram, amitriptyline.
  • Central nervous system depressants.
  • Metoclopramide and droperidol (medicines for treating nausea and vomiting).
  • Medicines containing St. John's Wort or valerian.
  • Androgens (for the treatment of male infertility).
  • Medicines for treating epilepsy.
  • Corticosteroids (medicines that reduce inflammation and allergic reactions).
  • Medicines for treating bacterial infections, such as metronidazole, sulfafurazol, isoniazid, and vancomycin.
  • Estrogen (for the treatment of menopause).
  • Medicines for treating diabetes, administered orally.
  • Antihypertensives (medicines administered to lower blood pressure), such as captopril, enalapril, terazosin, felodipine, hydralazine, losartan, methyldopa, moxonidine, nitrates, and diuretics.
  • Acetylsalicylic acid (aspirin) and other medicines for pain.
  • Antipsychotic medicines, such as lithium, promethazine, or quetiapine.
  • Diazoxide (for the treatment of low blood sugar levels).
  • Oral anticoagulants (medicines that thin the blood and prevent clot formation).

Using Tiobarbital B. Braun with alcohol

Before and even after anesthesia, do not consume any drink or food that contains alcohol in any case.

If you are dependent on alcohol or regularly take large amounts of alcohol, it may be necessary to increase the dose of tiopental.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

Pregnancy

Tiopental crosses the placental barrier. There are some data in pregnant women that indicate tiopental does not produce malformations or fetal/neonatal toxicity.

If you are pregnant, you will receive this medicine only if your doctor considers it appropriate.

Breastfeeding

Tiopental is excreted in breast milk, therefore breastfeeding should be temporarily suspended (at least 12 hours after the use of tiopental) or breast milk should be expressed before using this medicine.

Fertility

There are no data on the effect of tiopental on human fertility.

Driving and using machines

The influence of tiopental on the ability to drive and use machines is significant. You may experience dizziness (vertigo), disorientation, and sedation. Do not drive or use machines, especially during the first 24 to 36 hours after injection.

Tiobarbital B. Braun contains sodium

This medicine contains 92 mg of sodium per vial, equivalent to 4.6% of the maximum daily intake of 2 g of sodium recommended by the WHO for an adult.

3. How to use Tiobarbital B. Braun 1 g

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

This medicine will be administered by specialized personnel in the use of general anesthetics, who will be constantly available during administration, as well as resuscitation equipment.

This medicine will be administered directly into one of the blood vessels, a vein (intravenously).

You will be given a test dose of 25 to 75 mg to adjust the dose according to your needs.

Adults

General anesthesia

Your individual dose will be determined by the doctor and will be based on your age, sex, body weight, and general condition. You will receive an induction dose of 50 to 75 mg at intervals of 20 to 40 seconds and additional injections to maintain anesthesia of 25 to 50 mg.

Convulsive crises

The injection of tiopental is 50 to 125 mg and should be administered as soon as possible after the convulsion begins. Other doses may be needed to control the convulsions.

Cerebral hypertension

You will receive a dose of 1.5 to 3.5 mg per kg of body weight to reduce intracranial pressure (providing controlled ventilation).

Alteration of renal or hepatic function

Your doctor may reduce the dose of the tiopental injection if you have altered renal or hepatic function.

Elderly patients

A greater effect is expected in elderly patients, therefore the dose should be reduced.

Pediatric population

General anesthesia

The individual dose is adjusted according to the age, maturity, and general condition of the pediatric patient. You will receive an induction dose of approximately 3 to 6 mg per kg of body weight and additional injections to maintain anesthesia of 1 mg per kg of body weight.

Convulsive crises

An initial dose of 2 mg per kg of body weight is administered and then individually evaluated until the desired effect is achieved. Do not exceed the maximum dose of 5 mg/kg/h.

Cerebral hypertension

The safety and efficacy of tiopental in pediatric populations for treating increased cerebral pressure have not yet been established.

If you use more Tiobarbital B. Braun than you should

It is unlikely that this will happen, as your doctor will determine the necessary dose for you.

The most severe symptoms of overdose may occur between the first six hours and the five days following sudden withdrawal of the drug. These symptoms are the following:

  • severe drop in blood pressure
  • severe breathing difficulties
  • severe slow or irregular breathing

There are other less severe effects that may appear between eight and twelve hours after the last dose, with less frequent incidence:

  • prolonged drowsiness,
  • headache,
  • nausea, vomiting, and constipation.

In case of appearance of these effects, your doctor will immediately stop the use and treat you according to the symptoms that appear.

The most indicated treatment for overdose consists of maintaining correct ventilation with assisted breathing and even administering oxygen if necessary. It is advisable to monitor vital signs and, if renal function allows, induce diuresis by alkalizing the urine in order to eliminate the drug.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Consult your doctor immediately if you experience any of the following symptoms, you may need urgent medical treatment:

Frequency not known(cannot be estimated from the available data)

  • Difficulty breathing, wheezing, skin rash, itching, urticaria, and dizziness. This could be a severe allergic reaction.

Other side effects that may occur:

Common(may affect up to 1 in 10 people)

  • Cardiac arrhythmias (alteration of the normal heart rhythm).
  • Heart problems (such as myocardial depression).
  • Low blood pressure.
  • Drowsiness.
  • Delayed awakening from anesthesia.
  • Breathing difficulties.
  • Slow or insufficient breathing.
  • Difficulty swallowing, breathing, or speaking (laryngospasm).
  • Cough.
  • Snoring.
  • Sneezing.
  • Chills.
  • Formation of clots within blood vessels.
  • Inflammation of a vein.
  • Pain at the injection site.

Rare(may affect up to 1 in 1,000 people)

  • Severe allergic reaction.

Frequency not known(cannot be estimated from the available data)

  • Increased potassium levels in the blood (hyperkalemia).
  • Decreased potassium levels in the blood (hypokalemia).
  • Loss of appetite (anorexia).
  • General malaise.
  • Fatigue.
  • Headache.
  • Dizziness.
  • Confusion.
  • Memory loss.
  • Allergic reactions, skin reactions, hypersensitivity.

Initially, when this medicine is administered, laryngospasm, cough, and sneezing may occur. After the operation and the use of this medicine, vomiting is uncommon, but persistent drowsiness, confusion, memory loss (amnesia), and chills may occur.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Tiobarbital B. Braun 1 g

Keep this medicine out of the sight and reach of children.

No special storage conditions are required. Store in the original packaging to protect from light.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.

The contents of the vials should be used immediately after opening. Once the package is opened, discard the unused portion.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Content and Additional Information

Composition of Tiobarbital B. Braun 1 g

  • The active ingredient is thiopental sodium in the form of thiopental sodium and sodium carbonate. Each vial contains 1 g of thiopental sodium in the form of thiopental sodium and sodium carbonate.

Appearance of the Product and Container Content

Tiobarbital B. Braun 1 g is a powder for injectable solution. It is a crystalline white or yellowish-white powder packaged in glass vials.

It is presented packaged in boxes of 1 and 50 vials.

Marketing Authorization Holder:

  • Braun Medical, S.A.

Ctra. de Terrassa, 121

08191 Rubí (Barcelona),

Spain.

Manufacturer:

  • Braun Medical, S.A.

Ronda de los Olivares, Parcela 11,

Polígono Industrial Los Olivares,

23009 Jaén (Jaén),

Spain.

Date of the Last Revision of this Leaflet: April 2021

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

----------------------------------------------------------------------------------------------

This information is intended solely for doctors or healthcare professionals:

Solutions must be prepared aseptically with one of the following three diluents:

  • sterile water for injectable preparations
  • 0.9% sodium chloride solutions
  • 5% dextrose solution

The clinical concentrations used for intermittent intravenous administration vary between 2.0% and 5.0%.

A 2.0% or 2.5% solution is most frequently used. A concentration of 3.4% in sterile water for injection is isotonic; concentrations below 2.0% in this diluent are not used because they cause hemolysis. For continuous intravenous drip administration, concentrations of 0.2% or 0.4% are used. Solutions can be prepared by adding thiopental to a 5% dextrose solution or to a 0.9% sodium chloride solution.

CALCULATIONS FOR VARIOUS CONCENTRATIONS

Desired Concentration

Quantities to Use

%

mg/ml

g of Thiopental

ml of Solvent

0.2

2

1

500

0.4

4

1

250

2.0

20

1

50

2.5

25

1

40

5.0

50

1

20

The dissolution of Tiobarbital B. Braun must be carried out extemporaneously and aseptically.

Once the extemporaneous solution is prepared, it must be administered within a maximum period of 24 hours between 2°C and 8°C. Discard the residual volume of the solution.

This medicinal product is administered solely by the intravenous route. Extravasation or intra-arterial injection should be avoided. A person qualified in the use of anesthetics should be constantly available during the administration of the medicinal product. Intubation equipment, oxygen, and resuscitation equipment should be available.

The following corrective measures have been suggested in case of intra-arterial injection:

  1. Dilute the injected thiopental by removing the tourniquet and any constricting clothing.
  2. Leave the intravenous cannula in place, if possible.
  3. Inject a diluted solution of papaverine or lidocaine into the artery to inhibit smooth muscle spasm.
  4. If necessary, perform a sympathetic block of the brachial plexus and/or the stellate ganglion to relieve pain and help open up collateral circulation. Papaverine may be injected into the subclavian artery, if desired.
  5. Unless contraindicated, treat with heparin to prevent thrombus formation.
  6. Consider local infiltration of an alpha-adrenergic blocking agent such as phentolamine in the vasospastic area.
  7. Provide additional symptomatic treatment as necessary.

The solution should only be used if the container closure is not damaged and the solution is clear.

Incompatibilities

This medicinal product must not be mixed with other medicinal products, except those mentioned in section 6.6 of the technical leaflet.

Solutions reconstituted with Tiobarbital may cause an alkaline reaction and are incompatible with volume replacement solutions and acidic adjuvant anesthetic solutions, as this may lead to precipitation and blockage of the injection needle; similarly, chemical changes in the resulting solution cannot be ruled out.

Online doctors for TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION

Discuss questions about TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION is thiopental. This information helps identify medicines with the same composition but different brand names.

TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION is manufactured by B Braun Medical S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Psychiatrists, Neurologists, General medicine doctors, Pain medicine doctors, Anaesthesiologists may assess whether TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, TIOBARBITAL B. BRAUN 1 g POWDER FOR INJECTABLE SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (thiopental) include TIOBARBITAL B. BRAUN 0.5 g POWDER FOR INJECTABLE SOLUTION, ACTYNOX 50%/50% MEDICINAL COMPRESSED GAS, AERRANE 100% LIQUID FOR INHALATION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media